Pfizer To Put Big Marketing Muscle Behind Migraine With Biohaven Purchase

 
• By Jessica Merrill

Pfizer’s $11.6bn acquisition of the company brings it full rights to the oral migraine drug Nurtec ODT and nasal spray zevegepant, with aims to build a $6bn migraine franchise.

muscle
Pfizer plans to put big marketing muscle behind Nurtec • Source: Shutterstock

More from Deals

More from Business